Minghao Xu
Shanghai, China
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 19 publications
Cryogenic Thermoelectric Enhancement by Nonparabolic Band-Edge Transport in Bi2Te3.
Journal: Advanced materials (Deerfield Beach, Fla.)
Published: March 25, 2026
Activation of Nerve Growth Factor signaling limits the response to lenvatinib in hepatocellular carcinoma.
Journal: Signal transduction and targeted therapy
Published: September 16, 2025
FMO2+ cancer-associated fibroblasts sensitize anti-PD-1 therapy in patients with hepatocellular carcinoma.
Journal: Journal for immunotherapy of cancer
Published: April 14, 2025
Proteins from Stressed Mesenchymal Stem Cells Can Repair Hair Follicles and Promote Hair Regeneration.
Journal: ACS pharmacology & translational science
Published: March 12, 2025
CLDN4 palmitoylation promotes hepatic-to-biliary lineage transition and lenvatinib resistance in hepatocellular carcinoma.
Journal: Cell reports. Medicine
Published: January 17, 2025
WWOX tuning of oleic acid signaling orchestrates immunosuppressive macrophage polarization and sensitizes hepatocellular carcinoma to immunotherapy.
Journal: Journal for immunotherapy of cancer
Published: October 13, 2024
The Prognostic Significance of CTSV Expression in Patients with Hepatocellular Carcinoma.
Journal: International journal of general medicine
Published: May 08, 2024
FGFR2 fusion/rearrangement is associated with favorable prognosis and immunoactivation in patients with intrahepatic cholangiocarcinoma.
Journal: The oncologist
Published: March 02, 2024
Integration of HiBiT into enteroviruses: A universal tool for advancing enterovirus virology research.
Journal: Virologica Sinica
Published: November 22, 2023
Chemokine CCL21 determines immunotherapy response in hepatocellular carcinoma by affecting neutrophil polarization.
Journal: Cancer immunology, immunotherapy : CII
Published: November 17, 2023
Repolarization of Immunosuppressive Macrophages by Targeting SLAMF7-Regulated CCL2 Signaling Sensitizes Hepatocellular Carcinoma to Immunotherapy.
Journal: Cancer research
Published: October 08, 2023
Last Updated: 09/26/2026